Pharmagreen Biotech Inc. (PHBI)

Pharmagreen Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 12, 2026	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	1	3	0	4	10	8
Market Cap Growth	-5.30%	594.36%	-90.92%	-57.81%	36.76%	-94.87%
Enterprise Value	1	3	1	5	11	8
Last Close Price	0.00	0.00	0.00	0.01	0.03	0.08
PS Ratio	230.30	817.39	133.90	-	-	-
PB Ratio	-0.29	-0.89	-0.18	-2.43	-6.19	-2.61
EV/Sales Ratio	-	907.68	249.79	-	-	-
Debt / Equity Ratio	-0.15	-0.11	-0.17	-0.19	-0.16	-0.24
Net Debt / Equity Ratio	-0.15	-0.11	-0.17	-0.18	-0.14	-0.24
Net Debt / FCF Ratio	-10.66	-12.67	-5.03	-0.77	-1.19	-1.16
Asset Turnover	0.03	0.03	0.02	-	-	-
Inventory Turnover	0.20	0.20	-	-	-	-
Quick Ratio	0.00	0	0.00	0.00	0.01	0.00
Current Ratio	0.04	0.00	0.02	0.11	0.18	0.08
Return on Assets (ROA)	-139.13%	-141.50%	-179.26%	-229.74%	-147.17%	-67.73%
Return on Capital Employed (ROCE)	10.10%	8.20%	22.70%	62.80%	45.50%	16.70%
Earnings Yield	-32.73%	-36.04%	-141.69%	-19.80%	-43.24%	-31.81%
FCF Yield	-	-1.01%	-18.39%	-9.64%	-1.97%	-7.93%
Buyback Yield / Dilution	-28.47%	-41.33%	-15.55%	-37.46%	-257.86%	-10.82%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error